| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.073 | 16.755 | 33.539 | 40.874 | 42.390 | 62.254 | 60.018 | 74.862 | 124.613 |
| Total Income - EUR | - | 2.073 | 16.872 | 33.539 | 40.875 | 42.443 | 62.375 | 60.020 | 74.862 | 124.614 |
| Total Expenses - EUR | - | 4.175 | 7.063 | 20.954 | 22.703 | 21.834 | 20.545 | 23.445 | 33.140 | 72.184 |
| Gross Profit/Loss - EUR | - | -2.102 | 9.809 | 12.586 | 18.171 | 20.608 | 41.830 | 36.575 | 41.722 | 52.430 |
| Net Profit/Loss - EUR | - | -2.164 | 9.306 | 11.579 | 16.945 | 19.556 | 39.962 | 35.094 | 40.974 | 48.692 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Insight Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 19 | 44 | 79.196 | 70.320 | 62.792 | 54.222 | 46.524 | 75.651 | 67.316 |
| Current Assets | - | 821 | 8.168 | 3.600 | 10.305 | 16.763 | 45.099 | 5.414 | 10.826 | 14.814 |
| Inventories | - | 203 | 1.016 | 1.555 | 1.527 | 1.637 | 1.886 | 2.240 | 2.468 | 2.679 |
| Receivables | - | 33 | 501 | 0 | 3.535 | 1.429 | 5.951 | 269 | 4.549 | 4.254 |
| Cash | - | 585 | 6.650 | 2.044 | 5.243 | 13.697 | 37.262 | 2.905 | 3.810 | 7.881 |
| Shareholders Funds | - | -2.120 | 7.222 | 18.669 | 35.253 | 52.291 | 86.838 | 50.791 | 45.112 | 49.081 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.961 | 989 | 64.127 | 45.372 | 27.264 | 12.483 | 1.147 | 41.365 | 33.050 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Insight Med Srl